In the pursuit of solutions to complex global challenges including disease, energy demands, and climate change, scientific ...

This new article publication from Acta Pharmaceutica Sinica B, discusses how an innovative and stable mRNA-LNP microneedle vaccine elicits humoral and multifunctional cellular immune responses.

SARS-CoV-2 is a new kind of coronavirus that appeared suddenly in late 2019. The disease it causes, called COVID-19, is now ...

Even after COVID-19 clears from your system, its viral remnants (known as "zombie" fragments) keep hunting your immune cells.

Two major trials show metformin taken during acute COVID-19 lowers long COVID risk, is safe, and could be added to outpatient ...

Llama antibodies clamp the coronavirus shut at its weakest spot—leaving the virus powerless to mutate or infect.

Scientists are closely watching SARS-CoV-2 to track mutations and see if it's developed into different strains. So, has it?

New evidence suggests that mpox may be circulating quietly among healthy Nigerians, with some infections occurring without ...

With no approved pediatric treatments, Lin wonders whether Serena will be able to attend college. As a community representative for the U.S. National Institutes of Health’s long COVID clinical trials ...

Experts warn that two animal-borne pathogens capable of human transmission could spread further without better surveillance ...

Zoonotic vaccines form an essential frontier in infectious disease prevention, bridging the gap between human and animal health. Zoonotic diseases, caused ...

A detailed analysis of immune cells in Long COVID patients has revealed a previously unknown molecular signature linked to ...